Table: Anest Iwata -2025/26 group results
May 12 (Reuters)-
Anest Iwata Corp
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2026 Mar 31, 2025 Mar 31, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 55.91 54.41 60.00 29.15
(+2.8 pct) (+1.8 pct) (+7.3 pct) (+10.7 pct)
Operating 5.56 5.90 5.20 2.21
(-5.8 pct) (-4.4 pct) (-6.5 pct) (-12.0 pct)
Recurring 7.72 7.14 6.46 2.82
(+8.1 pct) (-10.6 pct) (-16.3 pct) (-14.4 pct)
Net
Net 5.36 4.28 3.95 1.75
(+25.2 pct) (-13.3 pct) (-26.3 pct) (-19.0 pct)
EPS 136.04 yen 108.21 yen 100.29 yen 44.43 yen
Ann Div 87.00 yen 45.00 yen 93.00 yen
-Q2 Div 41.00 yen 22.00 yen 43.00 yen
-Q4 Div 46.00 yen 23.00 yen 50.00 yen
NOTE - Anest Iwata Corp.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6381.T
Recent news on Anest Iwata
See all newsBrief: Anest Iwata Corp - To Buy Back Up To 2.53% Own Shares Worth 1.5 Billion Yen
Table: Anest Iwata -2025/26 group results
Table: Anest Iwata -2025/26 parent results
Brief: China's Chery, Japan's Autobacs Seven Have Set Up JV To Sell Electric Vehicles In Japan From 2027, Nikkei Says
Table: Anest Iwata - 9-MTH group results